Cardiovascular Diseases — Determinants of Cardiovascular Disease, Kidney Disease and Diabetes
Citation(s)
1 GSTT Charity report: From one to many. Exploring people's progression to multiple longterm conditions in an urban environment. Guy's and St. Thomas' Charity, London, July 2018. p10. 2. Public Health England. HIV in the UK 2016 report.
2 Public Health England. HIV in the UK 2016 report. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment _data/file/602942/HIV_in_the_UK_report.pdf
3 Public Health England. Hepatitis B in London 2016 data. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment _data/file/801174/London_hepatitis_B_report_2016.pdf
4 Public Health England. Positive Voices: The National Survey of People Living with HIV. Findings from the 2017 Survey. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/857922/PHE_positive_voices_report_2019.pdf
Braun, V and V. Clarke (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3 (2), 77-101.
Braveman P, Egerter S, Williams DR The social determinants of health: coming of age. Annu Rev Public Health. 2011;32:381-98. doi: 10.1146/annurev-publhealth-031210-101218. Review.
Braveman P, Gottlieb L The social determinants of health: it's time to consider the causes of the causes. Public Health Rep. 2014 Jan-Feb;129 Suppl 2:19-31. Review.
Chang J, Ma JZ, Zeng Q, Cechova S, Gantz A, Nievergelt C, O'Connor D, Lipkowitz M, Le TH Loss of GSTM1, a NRF2 target, is associated with accelerated progression of hypertensive kidney disease in the African American Study of Kidney Disease (AASK). Am J Physiol Renal Physiol. 2013 Feb 15;304(4):F348-55. doi: 10.1152/ajprenal.00568.2012. Epub 2012 Dec 5.
Malterud K Qualitative research: standards, challenges, and guidelines. Lancet. 2001 Aug 11;358(9280):483-8.
Mendenhall E, Kohrt BA, Norris SA, Ndetei D, Prabhakaran D Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations. Lancet. 2017 Mar 4;389(10072):951-963. doi: 10.1016/S0140-6736(17)30402-6. Review.
Seale, C (1999). Doing Qualitative Research: a Practical Handbook, D. Silverman, ed., Sage Publications, London, pp. 73-85, 119-138, and 154-172.
Singer M, Bulled N, Ostrach B, Mendenhall E Syndemics and the biosocial conception of health. Lancet. 2017 Mar 4;389(10072):941-950. doi: 10.1016/S0140-6736(17)30003-X. Review.
Sousa D (2014) Validation in Qualitative Research: General Aspects and Specificities of the Descriptive Phenomenological Method, Qualitative Research in Psychology, 11:2, 211-227.
The Lancet Syndemics: health in context. Lancet. 2017 Mar 4;389(10072):881. doi: 10.1016/S0140-6736(17)30640-2.
Tsai AC, Mendenhall E, Trostle JA, Kawachi I Co-occurring epidemics, syndemics, and population health. Lancet. 2017 Mar 4;389(10072):978-982. doi: 10.1016/S0140-6736(17)30403-8. Review.
Determinants of Cardiovascular Disease, Kidney Disease and Diabetes in People of African Ancestry With HIV (CKD Study)
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.